Stock BIOS BIOSENIC SA
Add to a list
To use this feature you must be a member
Log inSign up

Consensus BioSenic SA

Equities

BIOS

BE0974280126

Real-time Euronext Bruxelles
Other stock markets
 04:01:32 2024-04-26 am EDT 		5-day change 1st Jan Change
0.0155 EUR -4.91% Intraday chart for BioSenic SA -20.92% -74.67%
Apr. 11 Biosenic: launch of a debt restructuring plan CF
Mar. 12 Biosenic S.A. Releases Details of Optimized Administration Approach Ahead of Planned Phase 3 Trial of OATO for Chronic Graft-Versus-Host Disease CI

Evolution of the average Target Price on BioSenic SA

Price target over the last 5 years

History of analyst recommendation changes

736.Anv_hVgj29_EKRsYphAyZmPkfEGmDPW7YdAjL83OqGY.Qy2S3SkS64uNYVJ9kiNEEC2OEySRQ57iIudGfv-I-lBnTbPRIGCei71fLw~bdb1b21824e6df0610a4ce79646fc190

Analyst Recommendations on BioSenic SA

ANALYST RECOMMENDATIONS : AT&T, BancorpSouth Bank, CMO Group, Magnite, Textron... Our Logo
Bone Therapeutics Allogeneic Cell Therapy Product, ALLOB, Shows 90% Fusion Rate at 24 Months in Phase IIa Study in Lumbar Spinal Fusion CI
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
SELL
Number of Analysts
1
Last Close Price
0.0163 EUR
Average target price
0.1 EUR
Spread / Average Target
+513.50%
High Price Target
0.1 EUR
Spread / Highest target
+513.50%
Low Price Target
0.1 EUR
Spread / Lowest Target
+513.50%

Consensus detail

Consensus revision (last 18 months)

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. BIOS Stock
  4. Consensus BioSenic SA